Clinical Practice Points on the Diagnosis, Assessment and Management of ADHD in Children and Adolescents discusses the use of medications, psychological and educational strategies as other management options for some children/adolescents.

Publication Data

Reference number
MH26
ISBN
1864965622
Current

Clinical Practice Points are a resource that outlines good clinical practice based on the consensus of an expert working group.

The Clinical Practice Points on the Diagnosis, Assessment and Management of ADHD in Children and Adolescents (the CPPs) aim to provide clarity to clinicians on one of the most controversial areas in ADHD - the use of medication, in particular stimulants, in managing children and adolescents with ADHD symptoms. The CPPs also discuss psychological and educational strategies as other management options for some children/adolescents.

The CPPs will be most useful for GPs, paediatricians (including paediatric neurologists), child/adolescent psychiatrists, clinical and neuro-psychologists, allied health professionals and special educators who are working with children and adolescents with ADHD.

The CPPs cover assessment, diagnosis and management in children/adolescents.  They stress the importance of looking for alternative explanations for the child’s behaviour, and encourage clinicians to involve parents/carers and teachers in the assessment, management and review of each child/adolescent.

Note: The Royal Australasian College of Physicians developed Draft Australian Guidelines on Attention Deficit Hyperactivity Disorder (the Draft Guidelines) in 2009. The Draft Guidelines aim to provide health professionals with a guide to assessment, management and care of preschoolers, children, adolescents and adults with ADHD. The Draft Guidelines were considered but not approved by the Council of NHMRC on 2 December 2011, but are accessible on RACP’s wesbite. During November 2009 to 19 December 2013, the Draft Guidelines were available on the NHMRC website.